Effect of Noninvasive Ventilation on Tracheal Reintubation Among Patients With Hypoxemic Respiratory Failure Following Abdominal Surgery

Jaber, Samir; Lescot, Thomas; Futier, Emmanuel; Paugam–Burtz, Catherine; Séguin, Philippe; Ferrandière, Martine; Lasocki, Sigismond; Mimoz, Olivier; Hengy, Baptiste; Sannini, Antoine; Pottecher, Julien; Abback, Paër-Sélim; Riu, Béatrice; Belafia, Fouad; Constantin, Jean-Michel; Masseret, Élodie; Beaussier, Marc; Verzilli, Daniel; Jong, Audrey De; Chanques, Gérald; Brochard, Laurent; Molinari, Nicolas

doi:10.1001/jama.2016.2706

Cited by 188 publications

(137 citation statements)

References 39 publications

Supporting

Mentioning

123

Contrasting

Unclassified

Order By: Relevance

“…Non-invasive ventilation has been demonstrated to be beneficial for the outcome of patients with acute exacerbation of chronic obstructive pulmonary disease, acute cardiogenic pulmonary oedema, and more recently in the weaning/post-extubation management oe ARF. Non-invasive ventilation can also prevent intubation in selected patients with severe hypoxemic or de novo ARF [3], particularly in the postoperative period [4]. However, its clinical benefit remains controversial for the management of hypoxemic patients [5].…”

mentioning

confidence: 99%

Non-invasive ventilation in hypoxemic acute respiratory failure: is it still possible?

2017

View full text Add to dashboard Cite

mentioning

confidence: 99%

Non-invasive ventilation in hypoxemic acute respiratory failure: is it still possible?

2017

View full text Add to dashboard Cite

“…Recent randomised controlled trials have demonstrated that continuous positive airway pressure (CPAP) or bi-level positive airway pressure are better than standard oxygen devices in the postoperative period [47,48] and are increasingly used in patients undergoing cardiothoracic surgery in order to prevent or treat postoperative ARF [49][50][51]. In an attempt to compare NHF with these techniques, a current randomised noninferiority trial [52] in post-cardiothoracic surgery patients compared the use of NHF to NIV; similar rates of treatment failure, discomfort and ICU mortality were detected in both study groups.…”

Section: No Benefitmentioning

confidence: 99%

Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device

2017

View full text Add to dashboard Cite

Nasal high flow is a promising novel oxygen delivery device, whose mechanisms of action offer some beneficial effects over conventional oxygen systems. The administration of a high flow of heated and humidified gas mixture promotes higher and more stable inspiratory oxygen fraction values, decreases anatomical dead space and generates a positive airway pressure that can reduce the work of breathing and enhance patient comfort and tolerance. Nasal high flow has been used as a prophylactic tool or as a treatment device mostly in patients with acute hypoxaemic respiratory failure, with the majority of studies showing positive results. Recently, its clinical indications have been expanded to post-extubated patients in intensive care or following surgery, for pre-and peri-oxygenation during intubation, during bronchoscopy, in immunocompromised patients and in patients with "do not intubate" status. In the present review, we differentiate studies that suggest an advantage (benefit) from other studies that do not suggest an advantage (no benefit) compared to conventional oxygen devices or noninvasive ventilation, and propose an algorithm in cases of nasal high flow application in patients with acute hypoxaemic respiratory failure of almost any cause.

show abstract

“…The ability to identify such patients, however, remains elusive. (4) Avoidance of reintubation: NIV is advised in patients with hypoxemic ARF following abdominal surgery, as it reduces the risk of tracheal reintubation compared to standard oxygen therapy [4]. Recent studies suggest that in a preventive setting, HFNC could be considered in high-and low-risk intubated patients [5,6].…”

Section: New Parameters For Monitoring Invasive Mechanical Ventilationmentioning

confidence: 99%

“…In immunocompromised patients with hypoxemic ARF, no significant difference was observed in intubation rates, duration of mechanical ventilation, hospital stay, or mortality between NIV and standard oxygen therapy or HFNC [3]. In postoperative patients with hypoxemic ARF following abdominal surgery, NIV reduced the risk of tracheal reintubation as well as the incidence of nosocomial infection compared to standard oxygen therapy [4]. Similar to NIV, the use of HFNC is becoming increasingly common [5].…”

mentioning

confidence: 99%

Focus on ventilation and airway management in the ICU

2017

Self Cite

View full text Add to dashboard Cite

Effect of Noninvasive Ventilation on Tracheal Reintubation Among Patients With Hypoxemic Respiratory Failure Following Abdominal Surgery

Cited by 188 publications

References 39 publications

Non-invasive ventilation in hypoxemic acute respiratory failure: is it still possible?

Non-invasive ventilation in hypoxemic acute respiratory failure: is it still possible?

Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device

Focus on ventilation and airway management in the ICU

Contact Info

Product

Resources

About